Alpha 2.0
Login Register
» Articles » PMID: 35344390

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2022 Mar 28
PMID 35344390
Authors
Philip James Johnson
David J Pinato
Anton Kalyuzhnyy
Hidenori Toyoda
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.

Gairing S, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C JHEP Rep. 2025; 7(3):101295.

PMID: 40059970 PMC: 11889551. DOI: 10.1016/j.jhepr.2024.101295.

Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension.

Zhao C, Ren C, Yuan Z, Bai G, Li J, Gao L World J Gastrointest Surg. 2024; 16(7):2054-2064.

PMID: 39087107 PMC: 11287704. DOI: 10.4240/wjgs.v16.i7.2054.

Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study.

Storandt M, Zemla T, Patell K, Naleid N, Gile J, Tran N Oncologist. 2024; 29(11):986-996.

PMID: 38979643 PMC: 11546648. DOI: 10.1093/oncolo/oyae142.

Association of easy albumin-bilirubin score with increased mortality in adult trauma patients.

Hsu S, Rau C, Tsai C, Chou S, Su W, Hsieh C Front Surg. 2024; 11:1280617.

PMID: 38721021 PMC: 11076689. DOI: 10.3389/fsurg.2024.1280617.

ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma.

Tian Y, Niu H, Xu F, Shang-Guan P, Song W Sci Rep. 2024; 14(1):8034.

PMID: 38580647 PMC: 10997654. DOI: 10.1038/s41598-024-58205-5.